Abstract:Objective To investigate the role of leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) in U251 cells and its gene changes.Methods The stable cell line over-expressed LRIG1 (PEGFP-LRIG1) was established; PEGFP-N1-U251 cells and blank-U251 cells were used as controls.The expression changes ofLRIG1,GDNF and topoisomerase Ⅱ (TOPOⅡ) were detected by real time-PCR; Western blotting was employed to detect the LRIG1 protein expression; the growth curve of PEGFP-LRIG1-U251 cells and PEGFP-N1-U251 cells was drew from the 1st to 5th d,and the cell inhibition rate of temozolomide in these two groups was calculated.And then,siGDNF+siLRIG1 was performed to knock down the expressions of GDNF and LRIG1; besides that,siGDNF,siLRIG1 and/or blank control group were employed as controls to compare the proliferation index.Results The LRIG1 gene and protein expressions,GDNF and TOPOⅡ gene expressions were significantly different among the three groups (P＜0.05); the gene and protein expressions of LRIG1 were up-regulated and GDNF and TOPOⅡ gene expressions were down-regulated in the stable cell line LRIG1-U251 as compared with those in the PEGFP-N1-U251 cells and blank-U521 cells (P＜0.05).Cell counting in the stable cell line LRIG1-U251 was significantly lower than that in the PEGFP-N1-U251 cells on the 1-5 d of growth (P＜0.05).After temozolomide was added,cell inhabitation rate in the PEGFP-LRIG1-U251 group was obviously higher that that in the PEGFP-N1-U251 group (P＜0.05).SiGDNF+siLRIG1 could successfully knock down the expressions of LRIG1 and GDNF; the inhabitation rate of siLRIG1 was significantly higher than that of blank control group,and the that of siGDNF+siLRIG1 group was significantly lower than that in the siLRIGI group (P＜0.05).Conclusion LRIG1 can regulate proliferation of U251 cells by regulating GDNF.LRIG1 can inhibit GDNF and TOPOⅡ expressions and improve the chemosensitivity of U251 cells.

Relationship Between Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 with Chemotherapy Sensitivity in Glioma Cells

LRIG1 Dictates the Chemo-Sensitivity of Temozolomide (TMZ) in U251 Glioblastoma Cells Via Down-Regulation of EGFR/topoisomerase-2/Bcl-2

miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.

Increased Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 Expression Enhances Chemosensitivity in Glioma

LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells.

Dnmt1 Mediates Chemosensitivity By Reducing Methylation Of Mirna-20a Promoter In Glioma Cells

Effect of Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 on Glioma Cell Line U251

Effects of LRIG1 Expression on Radiosensitivity of Human Glioma Cells and the Possible Mechanism

LRIG 1 Enhances the Radiosensitivity of Radioresistant Human Glioblastoma U 251 Cells Via Attenuation of the EGFR / Akt Signaling Pathway

LRIG1 Improves Chemosensitivity Through Inhibition of BCL-2 and MnSOD in Glioblastoma

Effect of LRIG1 on cell proliferation of glioma cell line U251

Effect of over-expressed LRIG3 on cell cycle and survival of glioma cells

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.

Clinicopathological and Prognostic Significance of Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) in Malignant Tumors: A Meta-Analysis

[LRIG3 Gene Regulates Biological Activity of GL15 Cell Line].

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy

A Role for LRIG1 in the Regulation of Malignant Glioma Aggressiveness.

The Relationship of the Expression Level of Glycosphingolipids in Human Glioblastoma Cell Line A172, U251 and U251/VM-26 and Drug Resistance

[Relations Between RRM1 Protein Expression Levels and Effects of Gemcitabine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients].

Exosomal Connexin 43 Regulates the Resistance of Glioma Cells to Temozolomide